Caspofungin in the treatment of oropharyngeal candidiasis

被引：0
|
作者：
Garbino, J
Lew, D
Hirschel, B
Rohner, P
机构：
[1] Univ Hosp Geneva, Div Infect Dis, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Clin Microbiol Lab, CH-1211 Geneva 14, Switzerland
来源：
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE | 2003年 / 57卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A patient with AIDS developed oropharyngeal candidiasis. Candida albicans and C. glabrata were isolated from the patient and found to be resistant to fluconazole and itraconazole in vitro. Voriconazole therapy was initiated, but discontinued when the C. albicans strain isolated from the patient was found to be resistant to it. The patient failed to respond to subsequent therapy with a combination of amphotericin B and 5-flucytosine. Therapy with caspofungin was then initiated (70 mg loading dose, followed by 50 mg/day). The patient responded favourably to caspofungin, with complete resolution of signs and symptoms.
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [21] Economic evaluation of micafungin versus caspofungin for the treatment of candidaemia and invasive candidiasis
    Neoh, C. F.
    Liew, D.
    Slavin, M. A.
    Marriott, D.
    Chen, S. C. -A.
    Morrissey, O.
    Stewart, K.
    Kong, D. C. M.
    INTERNAL MEDICINE JOURNAL, 2013, 43 (06) : 668 - 677
  • [22] Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
    A Glöckner
    European Journal of Medical Research, 16 (4)
  • [23] Caspofungin therapy of neonates with invasive candidiasis
    Odio, CM
    Araya, R
    Pinto, LE
    Castro, CE
    Vasquez, S
    Alfaro, B
    Sàenz, A
    Herrera, ML
    Walsh, TJ
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2004, 23 (12) : 1093 - 1097
  • [24] Oropharyngeal candidiasis and radiotherapy
    Pinel, B.
    Cassou-Mounat, T.
    Bensadoun, R. -J.
    CANCER RADIOTHERAPIE, 2012, 16 (03): : 222 - 229
  • [25] Oropharyngeal Candidiasis #147
    Rosielle, Drew A.
    JOURNAL OF PALLIATIVE MEDICINE, 2010, 13 (12) : 1485 - 1486
  • [26] Miconazole in oropharyngeal candidiasis
    Reactions Weekly, 2005, 1054 (1) : 5 - 5
  • [27] Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: Relationship of MIC to treatment outcome
    Kartsonis, N
    Killar, J
    Mixson, L
    Hoe, CM
    Sable, C
    Bartizal, K
    Motyl, M
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) : 3616 - 3623
  • [28] An -azole antifungal indicated for the local treatment of oropharyngeal candidiasis in adults
    不详
    FORMULARY, 2010, 45 (06) : 178 - 178
  • [29] Head-to-head comparison of micafungin versus caspofungin in the treatment of invasive candidiasis
    Michael A. Pfaller
    Current Fungal Infection Reports, 2009, 3 (3) : 127 - 128
  • [30] Comment: Treatment of oropharyngeal candidiasis: More questions than answers
    Nadler, JP
    INFECTIONS IN MEDICINE, 1998, 15 (06) : 383 - 383
12345